Equities

Dr. Lal PathLabs Ltd

LALPATHLAB:NSI

Dr. Lal PathLabs Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)3,091.10
  • Today's Change29.15 / 0.95%
  • Shares traded112.92k
  • 1 Year change+15.04%
  • Beta0.7463
Data delayed at least 15 minutes, as of Nov 25 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments9,4268,1436,817
Total Receivables, Net1,1199531,083
Total Inventory388355551
Prepaid expenses164128139
Other current assets, total170152161
Total current assets11,2679,7318,752
Property, plant & equipment, net3,4704,0404,298
Goodwill, net5,4825,4785,434
Intangibles, net3,0433,5824,106
Long term investments337----
Note receivable - long term189216266
Other long term assets323405242
Total assets24,56023,85623,468
LIABILITIES
Accounts payable1,8661,5611,474
Accrued expenses------
Notes payable/short-term debt0700954
Current portion long-term debt/capital leases1,4391,3621,315
Other current liabilities, total1,3471,0751,257
Total current liabilities4,6524,6985,000
Total long term debt1,0302,1333,057
Total debt2,4694,1955,326
Deferred income tax242940
Minority interest361332355
Other liabilities, total------
Total liabilities6,0677,1938,451
SHAREHOLDERS EQUITY
Common stock835834833
Additional paid-in capital1,049935928
Retained earnings (accumulated deficit)16,75915,01813,417
Treasury stock - common(144)(119)(162)
Unrealized gain (loss)------
Other equity, total(6.09)(4.6)(0.76)
Total equity18,49316,66315,016
Total liabilities & shareholders' equity24,56023,85623,468
Total common shares outstanding838383
Treasury shares - common primary issue0.260.430.58
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.